These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17661532)

  • 1. Fludarabine: a review of its use in non-Hodgkin's lymphoma.
    Anderson VR; Perry CM
    Drugs; 2007; 67(11):1633-55. PubMed ID: 17661532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma.
    Zinzani PL
    Hematol J; 2004; 5 Suppl 1():S38-49. PubMed ID: 15079152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].
    Lü SQ; Yang JM; Song XM; Chen L; Zhang WP; Ni X; Xu XQ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):710-2. PubMed ID: 18246806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab.
    Alas S; Bonavida B; Emmanouilides C
    Anticancer Res; 2000; 20(5A):2961-6. PubMed ID: 11062708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients.
    Zinzani PL; Pellegrini C; Broccoli A; Gandolfi L; Stefoni V; Casadei B; Maglie R; Argnani L; Pileri S
    Hematol Oncol; 2015 Sep; 33(3):141-6. PubMed ID: 24986783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New prospects in the treatment of indolent lymphomas with purine analogues.
    Cheson BD
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
    Zinzani PL; Levrero MG; Lauria F; Rondelli D; Zaja F; Russo D; Fanin R; De Rossi G; Mauro FR; Bendandi M; Gozzetti A; Dianzani F; Mandelli F; Tura S
    Haematologica; 1994; 79(1):55-60. PubMed ID: 15378949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.
    Adkins JC; Peters DH; Markham A
    Drugs; 1997 Jun; 53(6):1005-37. PubMed ID: 9179529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma.
    Churn M; Clough V
    Clin Oncol (R Coll Radiol); 2001; 13(4):273-5. PubMed ID: 11554624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
    Roberts JD; Smith MR; Feldman EJ; Cragg L; Grant S
    Clin Lymphoma; 2002 Dec; 3(3):184-8. PubMed ID: 12521398
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma.
    Roberts JD; Smith MR; Feldman EJ; Cragg L; Millenson MM; Roboz GJ; Honeycutt C; Thune R; Padavic-Shaller K; Carter WH; Ramakrishnan V; Murgo AJ; Grant S
    Clin Cancer Res; 2006 Oct; 12(19):5809-16. PubMed ID: 17020988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma.
    Trojan A; Meier R; Licht A; Taverna C
    Ann Hematol; 2002 Sep; 81(9):535-7. PubMed ID: 12373357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine, mitoxantrone and dexamethasone as front-line therapy in elderly patients affected by newly-diagnosed, low-grade non-Hodgkin's lymphomas with unfavorable prognostic factors: results of a phase II study.
    Bordonaro R; Petralia G; Restuccia N; Todaro AM; Serraino D; Giuffrida D; Cordio S; Giannitto-Giorgio C; Salice P; Ursino M; Novello G; Marletta F; Manusia M
    Leuk Lymphoma; 2004 Jan; 45(1):93-100. PubMed ID: 15061203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma.
    Morris GJ; Millenson MM; Padavic-Shaller K; Wang H; Rogatko A; Clyde J; Boyd RL; Yeslow G; Halbherr T; Schilder RJ; Smith MR
    Haematologica; 2004 Dec; 89(12):1484-91. PubMed ID: 15590399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies.
    Johnson SA
    Hematol J; 2004; 5 Suppl 1():S50-61. PubMed ID: 15079153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma.
    Abbasi MR; Sparano JA; Sarta C; Wiernik PH
    Med Oncol; 2003; 20(1):53-8. PubMed ID: 12665685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing therapy for chronic lymphocytic leukemia--the role of rituximab.
    Hillmen P
    Semin Oncol; 2004 Feb; 31(1 Suppl 2):22-6. PubMed ID: 15042531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
    Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M
    Lancet Oncol; 2008 Apr; 9(4):352-8. PubMed ID: 18342572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.